Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2019 08:00 ET | Source: BioCardia, Inc.

BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery

SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
June 06, 2019 08:00 ET | Source: BioCardia, Inc.

BioCardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange

SAN CARLOS, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
May 23, 2019 15:23 ET | Source: BioCardia, Inc.

Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class

PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
May 20, 2019 08:00 ET | Source: BioCardia, Inc.

BioCardia Reports 2019 First Quarter Financial Results and Business Highlights

SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported...
May 08, 2019 08:00 ET | Source: BioCardia, Inc.

BioCardia Receives FDA Clearance for AVANCE Steerable Introducer for Transseptal Access to Heart

SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
October 05, 2015 20:32 ET | Source: BioCardia, Inc.

BioCardia to Present at 2015 Stem Cell Meeting on the Mesa

SAN CARLOS, Calif., Oct. 05, 2015 (GLOBE NEWSWIRE) -- BioCardia, Inc., a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases announced...